Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Highlights

  • Highlights
    Highlights of This Issue
    Clin Cancer Res July 1 2013 19 (13) 3329-3329;

CCR Translations

  • CCR Translations
    A Neu View of Invasive Lobular Breast Cancer
    Ron Bose
    Clin Cancer Res July 1 2013 19 (13) 3331-3333; DOI:10.1158/1078-0432.CCR-13-1031

  • CCR Translations
    Predicting Outcome by Images?
    Dirk De Ruysscher
    Clin Cancer Res July 1 2013 19 (13) 3334-3336; DOI:10.1158/1078-0432.CCR-13-1114

CCR New Strategies

  • CCR New Strategies
    New Strategies in the Treatment of Multiple Myeloma
    Nikhil C. Munshi and Kenneth C. Anderson
    Clin Cancer Res July 1 2013 19 (13) 3337-3344; DOI:10.1158/1078-0432.CCR-12-1881

Molecular Pathways

  • Molecular Pathways
    Molecular Pathways: Fumarate Hydratase-Deficient Kidney Cancer—Targeting the Warburg Effect in Cancer
    W. Marston Linehan and Tracey A. Rouault
    Clin Cancer Res July 1 2013 19 (13) 3345-3352; DOI:10.1158/1078-0432.CCR-13-0304

  • Molecular Pathways
    Molecular Pathways: Inhibiting Steroid Biosynthesis in Prostate Cancer
    Roberta Ferraldeschi, Nima Sharifi, Richard J. Auchus and Gerhardt Attard
    Clin Cancer Res July 1 2013 19 (13) 3353-3359; DOI:10.1158/1078-0432.CCR-12-0931

Review

  • Review
    Cell Trafficking of Endothelial Progenitor Cells in Tumor Progression
    Pilar de la Puente, Barbara Muz, Feda Azab and Abdel Kareem Azab
    Clin Cancer Res July 1 2013 19 (13) 3360-3368; DOI:10.1158/1078-0432.CCR-13-0462

Human Cancer Biology

  • Human Cancer Biology
    Identification and Selective Degradation of Neopeptide-Containing Truncated Mutant Proteins in the Tumors with High Microsatellite Instability
    Won Kyu Kim, Misun Park, Minhee Park, Yun Ji Kim, Nara Shin, Hyun Ki Kim, Kwon Tae You and Hoguen Kim
    Clin Cancer Res July 1 2013 19 (13) 3369-3382; DOI:10.1158/1078-0432.CCR-13-0684

  • Human Cancer Biology
    ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer
    Mohamed Kabbout, Melinda M. Garcia, Junya Fujimoto, Diane D. Liu, Denise Woods, Chi-Wan Chow, Gabriela Mendoza, Amin A. Momin, Brian P. James, Luisa Solis, Carmen Behrens, J. Jack Lee, Ignacio I. Wistuba and Humam Kadara
    Clin Cancer Res July 1 2013 19 (13) 3383-3395; DOI:10.1158/1078-0432.CCR-13-0341

  • Human Cancer Biology
    High Prevalence of BRCA1 and BRCA2 Germline Mutations with Loss of Heterozygosity in a Series of Resected Pancreatic Adenocarcinoma and Other Neoplastic Lesions
    Aimee L. Lucas, Reena Shakya, Marla D. Lipsyc, Elana B. Mitchel, Sheila Kumar, Caroline Hwang, Liyong Deng, Catherine Devoe, John A. Chabot, Matthias Szabolcs, Thomas Ludwig, Wendy K. Chung and Harold Frucht
    Clin Cancer Res July 1 2013 19 (13) 3396-3403; DOI:10.1158/1078-0432.CCR-12-3020

  • Human Cancer Biology | AuthorChoice
    Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
    Dominic E. Sanford, Brian A. Belt, Roheena Z. Panni, Allese Mayer, Anjali D. Deshpande, Danielle Carpenter, Jonathan B. Mitchem, Stacey M. Plambeck-Suess, Lori A. Worley, Brian D. Goetz, Andrea Wang-Gillam, Timothy J. Eberlein, David G. Denardo, Simon Peter Goedegebuure and David C. Linehan
    Clin Cancer Res July 1 2013 19 (13) 3404-3415; DOI:10.1158/1078-0432.CCR-13-0525

  • Human Cancer Biology | AuthorChoice
    RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy
    Mohammad Aminur Rahman, A.R.M. Ruhul Amin, Dongsheng Wang, Lydia Koenig, Sreenivas Nannapaneni, Zhengjia Chen, Zhibo Wang, Gabriel Sica, Xingming Deng, Zhuo (Georgia) Chen and Dong M. Shin
    Clin Cancer Res July 1 2013 19 (13) 3416-3428; DOI:10.1158/1078-0432.CCR-13-0073

  • Human Cancer Biology
    Downregulation of miR-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas
    Liping Liu, Kun Chen, Jueheng Wu, Ling Shi, Bo Hu, Shiyuan Cheng, Mengfeng Li and Libing Song
    Clin Cancer Res July 1 2013 19 (13) 3429-3438; DOI:10.1158/1078-0432.CCR-12-3794

  • Human Cancer Biology
    TIE-2 and VEGFR Kinase Activities Drive Immunosuppressive Function of TIE-2–Expressing Monocytes in Human Breast Tumors
    Mark Ibberson, Sylvian Bron, Nicolas Guex, Eveline Faes-van't Hull, Assia Ifticene-Treboux, Luc Henry, Hans-Anton Lehr, Jean-François Delaloye, George Coukos, Ioannis Xenarios and Marie-Agnès Doucey
    Clin Cancer Res July 1 2013 19 (13) 3439-3449; DOI:10.1158/1078-0432.CCR-12-3181

  • Human Cancer Biology
    Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
    Ken Kron, Dominique Trudel, Vaijayanti Pethe, Laurent Briollais, Neil Fleshner, Theodorus van der Kwast and Bharati Bapat
    Clin Cancer Res July 1 2013 19 (13) 3450-3461; DOI:10.1158/1078-0432.CCR-12-3139

  • Human Cancer Biology
    PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
    Benjamin J. Chen, Bjoern Chapuy, Jing Ouyang, Heather H. Sun, Margaretha G.M. Roemer, Mina L. Xu, Hongbo Yu, Christopher D.M. Fletcher, Gordon J. Freeman, Margaret A. Shipp and Scott J. Rodig
    Clin Cancer Res July 1 2013 19 (13) 3462-3473; DOI:10.1158/1078-0432.CCR-13-0855

  • Human Cancer Biology | AuthorChoice
    Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with BRCA1 and BRCA2 Mutations
    Joshy George, Kathryn Alsop, Dariush Etemadmoghadam, Heather Hondow, Thomas Mikeska, Alexander Dobrovic, Anna deFazio, for the Australian Ovarian Cancer Study Group, Gordon K. Smyth, Douglas A. Levine, Gillian Mitchell and David D. Bowtell
    Clin Cancer Res July 1 2013 19 (13) 3474-3484; DOI:10.1158/1078-0432.CCR-13-0066

  • Human Cancer Biology
    A NOTCH3 Transcriptional Module Induces Cell Motility in Neuroblastoma
    Johan van Nes, Alvin Chan, Tim van Groningen, Peter van Sluis, Jan Koster and Rogier Versteeg
    Clin Cancer Res July 1 2013 19 (13) 3485-3494; DOI:10.1158/1078-0432.CCR-12-3021

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140
    Katia Beider, Elena Ribakovsky, Michal Abraham, Hanna Wald, Lola Weiss, Evgenia Rosenberg, Eithan Galun, Abraham Avigdor, Orly Eizenberg, Amnon Peled and Arnon Nagler
    Clin Cancer Res July 1 2013 19 (13) 3495-3507; DOI:10.1158/1078-0432.CCR-12-3015

  • Cancer Therapy: Preclinical | AuthorChoice
    Synergistic Effects of Metformin Treatment in Combination with Gefitinib, a Selective EGFR Tyrosine Kinase Inhibitor, in LKB1 Wild-type NSCLC Cell Lines
    Floriana Morgillo, Ferdinando Carlo Sasso, Carminia Maria Della Corte, Donata Vitagliano, Elena D'Aiuto, Teresa Troiani, Erika Martinelli, Ferdinando De Vita, Michele Orditura, Raffaele De Palma and Fortunato Ciardiello
    Clin Cancer Res July 1 2013 19 (13) 3508-3519; DOI:10.1158/1078-0432.CCR-12-2777

  • Cancer Therapy: Preclinical | Free Article
    NMS-E973, a Novel Synthetic Inhibitor of Hsp90 with Activity against Multiple Models of Drug Resistance to Targeted Agents, Including Intracranial Metastases
    Gianpaolo Fogliatto, Laura Gianellini, Maria G. Brasca, Elena Casale, Dario Ballinari, Marina Ciomei, Anna Degrassi, Anna De Ponti, Massimiliano Germani, Marco Guanci, Mauro Paolucci, Paolo Polucci, Micaela Russo, Francesco Sola, Barbara Valsasina, Carlo Visco, Fabio Zuccotto, Daniele Donati, Eduard Felder, Enrico Pesenti, Arturo Galvani, Sergio Mantegani and Antonella Isacchi
    Clin Cancer Res July 1 2013 19 (13) 3520-3532; DOI:10.1158/1078-0432.CCR-12-3512

  • Cancer Therapy: Preclinical
    PI3K Pathway Dependencies in Endometrioid Endometrial Cancer Cell Lines
    Britta Weigelt, Patricia H. Warne, Maryou B. Lambros, Jorge S. Reis-Filho and Julian Downward
    Clin Cancer Res July 1 2013 19 (13) 3533-3544; DOI:10.1158/1078-0432.CCR-12-3815

  • Cancer Therapy: Preclinical
    Immunomodulatory Monoclonal Antibodies Combined with Peptide Vaccination Provide Potent Immunotherapy in an Aggressive Murine Neuroblastoma Model
    Emily L. Williams, Stuart N. Dunn, Sonya James, Peter W. Johnson, Mark S. Cragg, Martin J. Glennie and Juliet C. Gray
    Clin Cancer Res July 1 2013 19 (13) 3545-3555; DOI:10.1158/1078-0432.CCR-12-3226

  • Cancer Therapy: Preclinical
    Therapeutic Enhancement of ER Stress by Insulin-Like Growth Factor I Sensitizes Myeloma Cells to Proteasomal Inhibitors
    Inès Tagoug, Lars Petter Jordheim, Stéphanie Herveau, Eva-Laure Matera, Anne-Laure Huber, Kamel Chettab, Serge Manié and Charles Dumontet
    Clin Cancer Res July 1 2013 19 (13) 3556-3566; DOI:10.1158/1078-0432.CCR-12-3134

  • Cancer Therapy: Preclinical
    Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy
    Jun Zhao, Mark Z. Ma, Hening Ren, Zhenqiu Liu, Martin J. Edelman, Hong Pan and Li Mao
    Clin Cancer Res July 1 2013 19 (13) 3567-3576; DOI:10.1158/1078-0432.CCR-12-3478

  • Cancer Therapy: Preclinical
    Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer
    Steffan T. Nawrocki, Kevin R. Kelly, Peter G. Smith, Claudia M. Espitia, Anthony Possemato, Sean A. Beausoleil, Michael Milhollen, Stephen Blakemore, Michael Thomas, Allison Berger and Jennifer S. Carew
    Clin Cancer Res July 1 2013 19 (13) 3577-3590; DOI:10.1158/1078-0432.CCR-12-3212

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Tumor Heterogeneity and Permeability as Measured on the CT Component of PET/CT Predict Survival in Patients with Non–Small Cell Lung Cancer
    Thida Win, Kenneth A. Miles, Sam M. Janes, Balaji Ganeshan, Manu Shastry, Raymondo Endozo, Marie Meagher, Robert I. Shortman, Simon Wan, Irfan Kayani, Peter J. Ell and Ashley M. Groves
    Clin Cancer Res July 1 2013 19 (13) 3591-3599; DOI:10.1158/1078-0432.CCR-12-1307

  • Imaging, Diagnosis, Prognosis
    MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls
    Ang Li, Jun Yu, Haeryoung Kim, Christopher L. Wolfgang, Marcia Irene Canto, Ralph H. Hruban and Michael Goggins
    Clin Cancer Res July 1 2013 19 (13) 3600-3610; DOI:10.1158/1078-0432.CCR-12-3092

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)
    Craig L. Slingluff Jr, Gina R. Petroni, Kerrington R. Molhoek, David L. Brautigan, Kimberly A. Chianese-Bullock, Amber L. Shada, Mark E. Smolkin, Walter C. Olson, Alison Gaucher, Cheryl Murphy Chase, William W. Grosh, Geoffrey R. Weiss, Aubrey G. Wagenseller, Anthony J. Olszanski, Lainie Martin, Sofia M. Shea, Gulsun Erdag, Prahlad Ram, Jeffrey E. Gershenwald and Michael J. Weber
    Clin Cancer Res July 1 2013 19 (13) 3611-3620; DOI:10.1158/1078-0432.CCR-12-3919

  • Cancer Therapy: Clinical
    Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer
    Ana M. Aparicio, Andrea L. Harzstark, Paul G. Corn, Sijin Wen, John C. Araujo, Shi-Ming Tu, Lance C. Pagliaro, Jeri Kim, Randall E. Millikan, Charles Ryan, Nizar M. Tannir, Amado J. Zurita, Paul Mathew, Wadih Arap, Patricia Troncoso, Peter F. Thall and Christopher J. Logothetis
    Clin Cancer Res July 1 2013 19 (13) 3621-3630; DOI:10.1158/1078-0432.CCR-12-3791

  • Cancer Therapy: Clinical
    Phase I Study of Pazopanib in Patients with Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study
    Stephen I. Shibata, Vincent Chung, Timothy W. Synold, Jeffrey A. Longmate, A. Benjamin Suttle, Lone H. Ottesen, Heinz-Josef Lenz, Shivaani Kummar, R. Donald Harvey, Anne L. Hamilton, Bert H. O'Neil, John Sarantopoulos, Patricia LoRusso, Michelle A. Rudek, Afshin Dowlati, Daniel L. Mulkerin, Chandra P. Belani, Leena Gandhi, S. Cecilia Lau, S. Percy Ivy and Edward M. Newman
    Clin Cancer Res July 1 2013 19 (13) 3631-3639; DOI:10.1158/1078-0432.CCR-12-3214

  • Cancer Therapy: Clinical
    Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients
    Jacalyn Rosenblatt, Irit Avivi, Baldev Vasir, Lynne Uhl, Nikhil C. Munshi, Tami Katz, Bimalangshu R. Dey, Poorvi Somaiya, Heidi Mills, Federico Campigotto, Edie Weller, Robin Joyce, James D. Levine, Dimitrios Tzachanis, Paul Richardson, Jacob Laubach, Noopur Raje, Vassiliki Boussiotis, Yan Emily Yuan, Lina Bisharat, Viki Held, Jacob Rowe, Kenneth Anderson, Donald Kufe and David Avigan
    Clin Cancer Res July 1 2013 19 (13) 3640-3648; DOI:10.1158/1078-0432.CCR-13-0282

  • Cancer Therapy: Clinical
    A Multicenter, First-in-Pediatrics, Phase 1, Pharmacokinetic and Pharmacodynamic Study of Ridaforolimus in Patients with Refractory Solid Tumors
    Lia Gore, Tanya M. Trippett, Howard M. Katzenstein, Jessica Boklan, Aru Narendran, Amy Smith, Margaret E. Macy, Katherine Rolla, for the Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC), Narayana Narashimhan, Rachel M. Squillace, Christopher D. Turner, Frank G. Haluska and Michael Nieder
    Clin Cancer Res July 1 2013 19 (13) 3649-3658; DOI:10.1158/1078-0432.CCR-12-3166

  • Cancer Therapy: Clinical
    A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease
    Razelle Kurzrock, Peter M. Voorhees, Corey Casper, Richard R. Furman, Luis Fayad, Sagar Lonial, Hossein Borghaei, Sundar Jagannath, Lubomir Sokol, Saad Z. Usmani, Helgi van de Velde, Xiang Qin, Thomas A. Puchalski, Brett Hall, Manjula Reddy, Ming Qi and Frits van Rhee
    Clin Cancer Res July 1 2013 19 (13) 3659-3670; DOI:10.1158/1078-0432.CCR-12-3349

  • Cancer Therapy: Clinical
    First-in-Human Phase I Dose-Escalation Study of the HSP90 Inhibitor AUY922 in Patients with Advanced Solid Tumors
    Cristiana Sessa, Geoffrey I. Shapiro, Kapil N. Bhalla, Carolyn Britten, Karen S. Jacks, Monica Mita, Vali Papadimitrakopoulou, Tim Pluard, Thomas A. Samuel, Mikhail Akimov, Cornelia Quadt, Cristina Fernandez-Ibarra, Hong Lu, Stuart Bailey, Sandra Chica and Udai Banerji
    Clin Cancer Res July 1 2013 19 (13) 3671-3680; DOI:10.1158/1078-0432.CCR-12-3404

Predictive Biomarkers and Personalized Medicine

  • Predictive Biomarkers and Personalized Medicine | AuthorChoice
    Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies
    Matthew J. Brauer, Guanglei Zhuang, Maike Schmidt, Jenny Yao, Xiumin Wu, Joshua S. Kaminker, Stefanie S. Jurinka, Ganesh Kolumam, Alicia S. Chung, Adrian Jubb, Zora Modrusan, Tomoko Ozawa, C. David James, Heidi Phillips, Benjamin Haley, Rachel N.W. Tam, Anne C. Clermont, Jason H. Cheng, Sherry X. Yang, Sandra M. Swain, Daniel Chen, Stefan J. Scherer, Hartmut Koeppen, Ru-Fang Yeh, Peng Yue, Jean-Philippe Stephan, Priti Hegde, Napoleone Ferrara, Mallika Singh and Carlos Bais
    Clin Cancer Res July 1 2013 19 (13) 3681-3692; DOI:10.1158/1078-0432.CCR-12-3635

  • Predictive Biomarkers and Personalized Medicine
    Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer
    Fabrice André, Thomas Bachelot, Mario Campone, Florence Dalenc, Jose M. Perez-Garcia, Sara A. Hurvitz, Nicholas Turner, Hope Rugo, John W. Smith, Stephanie Deudon, Michael Shi, Yong Zhang, Andrea Kay, Diana Graus Porta, Alejandro Yovine and José Baselga
    Clin Cancer Res July 1 2013 19 (13) 3693-3702; DOI:10.1158/1078-0432.CCR-13-0190

  • Predictive Biomarkers and Personalized Medicine
    Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer
    Jennifer B. Dennison, Jennifer R. Molina, Shreya Mitra, Ana M. González-Angulo, Justin M. Balko, María G. Kuba, Melinda E. Sanders, Joseph A. Pinto, Henry L. Gómez, Carlos L. Arteaga, Robert E. Brown and Gordon B. Mills
    Clin Cancer Res July 1 2013 19 (13) 3703-3713; DOI:10.1158/1078-0432.CCR-13-0623

Corrections

  • Corrections
    Correction: Translating the Therapeutic Potential of AZD4547 in FGFR1-Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
    Clin Cancer Res July 1 2013 19 (13) 3714-3714; DOI:10.1158/1078-0432.CCR-13-1265

  • Corrections
    Correction: c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met
    Clin Cancer Res July 1 2013 19 (13) 3715-3715; DOI:10.1158/1078-0432.CCR-13-1344

Back to top
PreviousNext
Clinical Cancer Research: 19 (13)
July 2013
Volume 19, Issue 13
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • NMS-E973, a Novel Synthetic Inhibitor of Hsp90 with Activity against Multiple Models of Drug Resistance to Targeted Agents, Including Intracranial Metastases
  • ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer
  • Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
  • A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

Jump to

  • Highlights
  • CCR Translations
  • CCR New Strategies
  • Molecular Pathways
  • Review
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Predictive Biomarkers and Personalized Medicine
  • Corrections
Advertisement
  • Most Cited
  • Most Read
Loading
  • scRNA-seq Analysis of Gastric Cancer TME
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
  • PDAC and GATA6 Expression
  • Rucaparib in mCRPC with a Non-BRCA DDR Gene Alteration
  • AR Gene Rearrangements in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement